Join to View Full Profile
9500 Euclid Avenue / U10Cleveland, OH 44195
Phone+1 216-444-8600
Dr. Conway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2006 - 2009
Yale-New Haven Medical CenterInternship, Internal Medicine, 2005 - 2006
Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
OH State Medical License 2006 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Gilenya's Impact on Cognitive Function and Thalamic Volumes Start of enrollment: 2017 Oct 20
Publications & Presentations
PubMed
- Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis care.Albert Aboseif, Justin R Abbatemarco, Marisa P McGinley, Julia O'Mahony, Devon S Conway
Multiple Sclerosis and Related Disorders. 2025-09-01 - De-escalation of disease modifying therapies: A retrospective, observational single center study.Carolyn Goldschmidt, Jordan Glassman, Brandon Ly, Devon S Conway, Mengke Du
Multiple Sclerosis and Related Disorders. 2025-08-01 - 1 citationsReal world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers.Devon S Conway, Jacqueline A Nicholas, Nicolas R Thompson, Ellen M Mowry, Robert T Naismith
Multiple Sclerosis and Related Disorders. 2025-02-01
Press Mentions
Multiple Sclerosis (MS): 4 Triggers That Can Make Symptoms WorseMay 8th, 2025- Multiple Sclerosis: Causes, Signs and TreatmentsMarch 10th, 2025
Effect of Tobacco Use on Disease Activity and DMT Discontinuation in Multiple Sclerosis Patients Treated with Dimethyl Fumarate or FingolimodOctober 13th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
